Navigation Links
LAB Research announces changes to its Board of Directors
Date:2/9/2009

www.labresearch.com

Toronto Stock Exchange Symbol: LRI

LAVAL, QC, Feb. 9 /PRNewswire-FirstCall/ - LAB Research Inc. ("LRI", "LAB Research" or the "Company") (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced the nomination of Mr. Carl A. Spalding as Chairman of its Board of Directors in replacement of Mr. Karsten Skydsgaard who previously communicated a wish to step down of the Board to focus on his other professional obligations.

"On behalf of the Board of Directors, I would like to thank Karsten for his dedication and contribution to LAB Research since our 2006 Initial Public Offering ("IPO"). His expertise, and continuous support toward the Company have played a key role in LRI's development and success," said Mr. Luc Mainville, Chief Executive Officer and President of LAB Research.

Mr. Spalding brings to LRI extensive operational experience and contacts in the global pharmaceutical and contract research organization industries. Mr. Spalding has held numerous senior executive positions such as President and Chief Operating Officer of PAREXEL International Corporation, Executive Vice President and Group President, Healthcare Products Services at Cardinal Health and Vice President and General Manager, Ross Products for Abbott Laboratories.

"I am impressed with the timely execution and completion of the growth and development strategy put forward by the Senior Management team at LRI since its 2006 IPO. I am also confident that the recently adopted measures to insure a swift improvement of the Company's financial performance will prove to be successful and look forward to actively participating in the continued success of LAB Research," commented Mr. Spalding.

"We are very fortunate to have someone of Carl's calibre and with such industry experience and relationships to assume the Chairmanship of LAB Research. Now that we have completed our expansion program and are positioned to benefit from the significant revenue capacity added, we will greatly benefit from Carl's strong global operational background and business insight as we strive towards improving our profitability and overall financial performance," added Mr. Luc Mainville.

About LAB Research Inc.:

LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petro-chemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.

LAB Research's shares trade on The Toronto Stock Exchange ("TSX") under the symbol "LRI", with 18.1 million shares outstanding.

This news release contains certain forward-looking statements that reflect the current views and/or expectations of LAB Research Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.


'/>"/>
SOURCE LAB RESEARCH INC.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Artemis Health Hires Richard Rava, Ph.D., as Senior Vice President of Research and Development
2. LAB research to present at upcoming UBS 2009 global healthcare services conference in New York
3. In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors
4. Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity
5. Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
6. Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
7. ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services
8. 23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
9. Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinsons Disease
10. NewCardio Joins the Cardiac Safety Research Consortium
11. Avantium Launches the Crystalline, a New Parallel System for Crystallization Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Personal Genome ... its cancer testing contract with the U.S. Department ... tumor profiling assay with the company,s new CancerSELECT ... comprehensive, clinically actionable pan-cancer profiling test that includes ... assess potential patient response to checkpoint inhibitor immunotherapies. ...
(Date:3/22/2017)... 22, 2017   Invitae Corporation (NYSE: ... companies, today announced the availability of a new ... Muscular Atrophy (SMA) , a neuromuscular disease that ... among infants as well as a significant cause ... test, announced during the American College of Medical ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... interfere with the ability of endogenous hormones to regulate homeostasis via their ... activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. EDC ...
(Date:3/20/2017)... ... March 20, 2017 , ... Avexegen ... today announced that it has entered into an exclusive global license agreement with ... disease including Necrotizing Enterocolitis (rare orphan disease) as well as Crohn’s Disease and ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
Breaking Biology News(10 mins):